AmSurg Executives Sell 26.5k Shares

Christopher Holden, CEO of AmSurg, has sold 3,000 shares of company stock, according to WKRB News & Analysis report. David Manning, executive vice president of AmSurg, has sold 23,500 shares of company stock, according to a Mideast Times report.

Advertisement

Mr. Holden’s stock sold at an average price of $47.37 per share, for a total transaction of $142,110. Mr. Holden now owns 285,198 company shares, which are valued at approximately $13.51 million.

Mr. Manning’s stock sold at an average price of $48.55 per share, for a total transaction of $1.14 million. Mr. Manning now owns 108,203 company shares, which is an estimated value of $5.25 million.

Both transactions were disclosed in filings with the U.S. Securities and Exchange Commission.

More Articles on Transactions and Valuation Issues:
ASC Company Services & Ownership: 7 Things to Know
How Does Physician Ownership Impact ASC Valuation? Q&A With VMG’s Aaron Murski
7 Statistics on ASC Offering Price

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.